Hemoglobin Cagliari (beta 60 [E4] Val----Glu): a novel unstable thalassemic hemoglobinopathy. 1991

A Podda, and R Galanello, and L Maccioni, and M A Melis, and C Rosatelli, and L Perseu, and A Cao
Istituto di Clinica e Biologia Etá Evolutiva, Universitá Studi Cagliari, Italy.

This report describes a patient with thalassemia intermedia-like phenotype born to normal parents in whom globin gene sequencing detected a novel abnormal hemoglobin (Hb) due to a T to A substitution at codon 60 of the beta-globin gene arising as a de novo mutation. Normal sequences were detected at the homologous beta-globin locus. This mutation results in the substitution of a polar (glutamic acid) for a nonpolar (valine) residue near the corner of the heme pocket of the beta-globin chain. The novel variant has been designated Hb Cagliari, from the place of birth of the propositus. Kinetics of globin synthesis performed following splenectomy suggest that this new Hb variant is synthesized at a near normal rate but undergoes rapid breakdown. The extreme lability of the variant explains the clinical and hematologic picture characterized by marked ineffective erythropoiesis, thalassemia-like bone changes, iron overload, high proportion of Hb F in the peripheral blood, reduced beta/alpha-globin chain synthesis ratio in peripheral blood reticulocytes, and absence of the abnormal Hb in peripheral blood at extensive protein structural analysis before splenectomy. This case indicates that a thalassemic hemoglobinopathy should be suspected in the presence of a patient with a thalassemia intermedia-like phenotype born to normal parents, even when protein structural analysis fails to detect an abnormal Hb. DNA sequencing may allow to define the mutation, thus making the proper diagnosis.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007526 Isoelectric Point The pH in solutions of proteins and related compounds at which the dipolar ions are at a maximum. Isoelectric Points,Point, Isoelectric,Points, Isoelectric
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009841 Oligonucleotides Polymers made up of a few (2-20) nucleotides. In molecular genetics, they refer to a short sequence synthesized to match a region where a mutation is known to occur, and then used as a probe (OLIGONUCLEOTIDE PROBES). (Dorland, 28th ed) Oligonucleotide
D005914 Globins A superfamily of proteins containing the globin fold which is composed of 6-8 alpha helices arranged in a characterstic HEME enclosing structure. Globin
D006455 Hemoglobins, Abnormal Hemoglobins characterized by structural alterations within the molecule. The alteration can be either absence, addition or substitution of one or more amino acids in the globin part of the molecule at selected positions in the polypeptide chains. Abnormal Hemoglobins
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000743 Anemia, Hemolytic A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES). Anemia, Hemolytic, Acquired,Anemia, Microangiopathic,Haemolytic Anaemia,Hemolytic Anemia,Hemolytic Anemia, Acquired,Microangiopathic Hemolytic Anemia,Acquired Hemolytic Anemia,Anaemia, Haemolytic,Anemia, Acquired Hemolytic,Anemia, Microangiopathic Hemolytic,Haemolytic Anaemias,Hemolytic Anemia, Microangiopathic,Microangiopathic Anemia,Microangiopathic Hemolytic Anemias
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D013789 Thalassemia A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia. Thalassemias

Related Publications

A Podda, and R Galanello, and L Maccioni, and M A Melis, and C Rosatelli, and L Perseu, and A Cao
January 1983, Hemoglobin,
A Podda, and R Galanello, and L Maccioni, and M A Melis, and C Rosatelli, and L Perseu, and A Cao
January 1987, Pathology,
A Podda, and R Galanello, and L Maccioni, and M A Melis, and C Rosatelli, and L Perseu, and A Cao
November 1973, Biochimica et biophysica acta,
A Podda, and R Galanello, and L Maccioni, and M A Melis, and C Rosatelli, and L Perseu, and A Cao
January 1979, Hemoglobin,
A Podda, and R Galanello, and L Maccioni, and M A Melis, and C Rosatelli, and L Perseu, and A Cao
January 2007, Hemoglobin,
A Podda, and R Galanello, and L Maccioni, and M A Melis, and C Rosatelli, and L Perseu, and A Cao
January 1975, Acta haematologica,
A Podda, and R Galanello, and L Maccioni, and M A Melis, and C Rosatelli, and L Perseu, and A Cao
January 1986, Hemoglobin,
A Podda, and R Galanello, and L Maccioni, and M A Melis, and C Rosatelli, and L Perseu, and A Cao
January 1989, Hemoglobin,
A Podda, and R Galanello, and L Maccioni, and M A Melis, and C Rosatelli, and L Perseu, and A Cao
August 1970, Blood,
A Podda, and R Galanello, and L Maccioni, and M A Melis, and C Rosatelli, and L Perseu, and A Cao
October 1977, Biochimica et biophysica acta,
Copied contents to your clipboard!